Ocular Therapeutix, Inc filed a Form 8-K with the U.S. Securities and Exchange Commission (SEC) at 12:28 UTC on Monday, 9 November 2026. The filing reports Item 5.02, Departure or Election of Directors or Certain Officers.
A Form 8-K is the report U.S. public companies file to tell investors about significant events between their regular quarterly and annual reports. Each item in the form covers one type of event.
Source: U.S. Securities and Exchange Commission (EDGAR) filing